ePrints@IIScePrints@IISc Home | About | Browse | Latest Additions | Advanced Search | Contact | Help

Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes

Ramachandran, Surya and Venugopal, Anila and Sathisha, K and Reshmi, G and Charles, Sona and Divya, G and Chandran, Pratap NS and Mullassari, Ajit and Pillai, Radhakrishna M and Kartha, CC (2012) Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes. In: PROTEOMICS, 12 (18). pp. 2808-2821.

Full text not available from this repository. (Request a copy)
Official URL: http://dx.doi.org/10.1002/pmic.201100586

Abstract

Hyperglycemia is widely recognized to be a potent stimulator of monocyte activity, which is a crucial event in the pathogenesis of atherosclerosis. We analyzed the monocyte proteome for potential markers that would enhance the ability to screen for early inflammatory status in Type 2 diabetes mellitus (T2DM), using proteomic technologies. Monocytic cells (THP-1) were primed with high glucose (HG), their protein profiles were analyzed using 2DE and the downregulated differentially expressed spots were identified using MALDI TOF/MS. We selected five proteins that were secretory in function with the help of bioinformatic programs. A predominantly downregulated protein identified as cyclophilin A (sequence coverage 98%) was further validated by immunoblotting experiments. The cellular mRNA levels of cyclophilin A in various HG-primed cells were studied using qRT-PCR assays and it was observed to decrease in a dose-dependent manner. LC-ESI-MS was used to identify this protein in the conditioned media of HG-primed cells and confirmed by Western blotting as well as ELISA. Cyclophilin A was also detected in the plasma of patients with diabetes. We conclude that cyclophilin A is secreted by monocytes in response to HG. Given the paracrine and autocrine actions of cyclophilin A, the secreted immunophilin could be significant for progression of atherosclerosis in type 2 diabetes. Our study also provides evidence that analysis of monocyte secretome is a viable strategy for identifying candidate plasma markers in diabetes.

Item Type: Journal Article
Publication: PROTEOMICS
Publisher: WILEY-BLACKWELL
Additional Information: Copyright for this article belongs to Wley
Keywords: Cell biology; Hyperglycemia; Monocytes; Type 2 diabetes mellitus
Department/Centre: Division of Biological Sciences > Molecular Biophysics Unit
Date Deposited: 02 Jan 2013 07:30
Last Modified: 02 Jan 2013 07:30
URI: http://eprints.iisc.ac.in/id/eprint/45234

Actions (login required)

View Item View Item